BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8363508)

  • 1. Immunohistochemical detection of Newcastle disease virus in chickens.
    Lockaby SB; Hoerr FJ; Ellis AC; Yu MS
    Avian Dis; 1993; 37(2):433-7. PubMed ID: 8363508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus isolation from tracheal explant cultures and oropharyngeal swabs in attempts to detect persistent Newcastle disease virus infections in chickens.
    King DJ
    Avian Dis; 1985; 29(2):297-311. PubMed ID: 4026728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newcastle disease virus pathogenesis in the respiratory tract of local or systemic immunized chickens.
    Levy R; Spira G; Zakay-Rones Z
    Avian Dis; 1975; 19(4):700-6. PubMed ID: 1200946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of an enzyme immunoassay for the detection of antibodies from hens and mice against Newcastle disease virus].
    Minning P; Hlinak A; Klaczinski K
    Berl Munch Tierarztl Wochenschr; 1993 May; 106(5):149-53. PubMed ID: 8512547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viscerotropic velogenic Newcastle disease in Turkeys: virus shedding and persistence of infection in susceptible and vaccinated poults.
    Gillette KG; Coria MF; Boney WA; Stone HD
    Avian Dis; 1975; 19(1):31-9. PubMed ID: 1120035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobilization of immunoglobulin (Ig)-containing plasma cells in Harderian gland, cecal tonsil and trachea of broilers vaccinated with Newcastle Disease Vaccine.
    Nasrin M; Khan MZ; Siddiqi MN; Masum MA
    Tissue Cell; 2013 Jun; 45(3):191-7. PubMed ID: 23395422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a recombinant fowl pox-based Newcastle disease virus vaccine candidate against velogenic and respiratory challenge.
    Taylor J; Christensen L; Gettig R; Goebel J; Bouquet JF; Mickle TR; Paoletti E
    Avian Dis; 1996; 40(1):173-80. PubMed ID: 8713031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of low virulent Newcastle disease virus infection in chickens infected with reticuloendotheliosis virus.
    Yoshida I; Sakata M; Fujita K; Noguchi T; Yuasa N
    Natl Inst Anim Health Q (Tokyo); 1981; 21(1):1-6. PubMed ID: 6264326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and persistence of infectious bursal disease virus in specific-pathogen-free and commercial broiler chickens.
    Abdel-Alim GA; Saif YM
    Avian Dis; 2001; 45(3):646-54. PubMed ID: 11569738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence and transmission of Newcastle disease virus aerosol originating from infected chickens under experimental conditions.
    Li X; Chai T; Wang Z; Song C; Cao H; Liu J; Zhang X; Wang W; Yao M; Miao Z
    Vet Microbiol; 2009 May; 136(3-4):226-32. PubMed ID: 19091492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental pathogenesis for chickens, turkeys, and pigeons of exotic Newcastle disease virus from an outbreak in California during 2002-2003.
    Wakamatsu N; King DJ; Kapczynski DR; Seal BS; Brown CC
    Vet Pathol; 2006 Nov; 43(6):925-33. PubMed ID: 17099149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological and pathological studies of Newcastle disease viruses isolated from caged birds from Southeast Asia.
    Kawamura M; Nerome K; Kodama H; Izawa H; Mikami T
    Avian Dis; 1987; 31(3):564-9. PubMed ID: 2960314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Newcastle disease virus on ocular and paraocular tissues in experimentally inoculated chickens.
    Obaldia N; Hanson RP
    Avian Dis; 1989; 33(2):285-90. PubMed ID: 2751562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lipopolysaccharide on intranasal administration of liposomal Newcastle disease virus vaccine to SPF chickens.
    Tseng LP; Chiou CJ; Chen CC; Deng MC; Chung TW; Huang YY; Liu DZ
    Vet Immunol Immunopathol; 2009 Oct; 131(3-4):285-9. PubMed ID: 19439366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response to Newcastle disease virus given by two different routes as measured by ELISA and hemagglutination-inhibition test and associated tracheal immunity.
    Marquardt WW; Snyder DB; Savage PK; Kadavil SK; Yancey FS
    Avian Dis; 1985; 29(1):71-9. PubMed ID: 3985884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of an infectious bursal disease virus intermediate vaccine in ovo.
    Coletti M; Del Rossi E; Franciosini MP; Passamonti F; Tacconi G; Marini C
    Avian Dis; 2001; 45(4):1036-43. PubMed ID: 11785875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viscerotropic velogenic Newcastle disease in turkeys: isolation of Newcastle disease virus from tracheal and cecal tonsil organ cultures.
    Coria MF; Gillette KG; Stone HD; Boney WA
    Avian Dis; 1975; 19(1):40-6. PubMed ID: 1120036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes.
    Loke CF; Omar AR; Raha AR; Yusoff K
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):259-67. PubMed ID: 15963824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.